Disease Progression, Treatment Patterns, and Outcomes in Schizophrenia Over a 3-Year Period: Results from the Cohort for the General Study of Schizophrenia (CGS)

被引：0
|
作者：
Jalbert, Jessica J. [1 ,2 ]
Rossignol, Michel [3 ,4 ]
Rouillon, Frederic [5 ,6 ]
Astruc, Bernard [7 ]
David, Benoit [3 ]
Benichou, Jacques [3 ,8 ]
Abenhaim, Lucien [9 ]
Grimaldi-Bensouda, Lamiae [3 ,10 ]
机构：
[1] LA SER Analytica, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] LA SER Res, Paris, France
[4] McGill Univ, Montreal, PQ, Canada
[5] Univ Paris 05, Ctr Hosp St Anne, Paris, France
[6] Hop St Anne, INSERM, U894, F-75674 Paris, France
[7] Eutelmed SAS, Fac Med Cochin Port Royal, Paris, France
[8] Ctr Hosp Univ Rouen, INSERM, U657, Rouen, France
[9] LA SER, London, England
[10] Conservatoire Natl Arts & Metiers, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
168
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [1] EVOLUTION OF DISEASE OUTCOMES IN SCHIZOPHRENIA: RESULTS FROM THE "COHORT FOR THE GENERAL STUDY OF SCHIZOPHRENIA (CGS)" WITH 3 YEARS OF FOLLOW-UP
    Jalbert, J. J.
    Rossignol, M.
    Rouillon, F.
    Astruc, B.
    Benichou, J.
    Abenhaim, L.
    Grimaldi-Bensouda, L.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A209 - A209
  • [2] Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France
    Gasquet, Isabelle
    Haro, Josep Maria
    Tcherny-Lessenot, Stephanie
    Chartier, Florence
    Lepine, Jean-Pierre
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 (07) : 491 - 496
  • [3] Baseline results from the Schizophrenia Outpatient Health Outcomes study (SOHO): A 3-year, pan-European, observational health outcomes study in schizophrenia
    Haro, JM
    Edgell, ET
    Frewer, P
    Novick, D
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 265 - 265
  • [4] Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)
    Grimaldi-Bensouda, Lamiae
    Rouillon, Frederic
    Astruc, Bernard
    Rossignol, Michel
    Benichou, Jacques
    Falissard, Bruno
    Limosin, Frederic
    Beaufils, Beatrice
    Vaiva, Guillaume
    Verdoux, Helene
    Moride, Yola
    Fabre, Alban
    Thibaut, Florence
    Abenhaim, Lucien
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 187 - 194
  • [5] Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study
    Treuer, T.
    Martenyi, F.
    Saylan, M.
    Dyachkova, Y.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (06) : 697 - 706
  • [6] Mortality in a cohort of outpatients with schizophrenia: 3-year outcomes from the intercontinental outpatient health outcomes study (IC-SOHO)
    Hoffmann, Vicki Poole
    Dossenbach, Martin
    West, Teena M.
    Lowry, Amanda J.
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 163S - 164S
  • [7] Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study
    O'Reilly, K.
    O'Connell, P.
    Donohoe, G.
    Coyle, C.
    O'Sullivan, D.
    Azvee, Z.
    Maddock, C.
    Sharma, K.
    Sadi, H.
    McMahon, M.
    Kennedy, H. G.
    [J]. PSYCHOLOGICAL MEDICINE, 2016, 46 (15) : 3199 - 3211
  • [8] Does Long-Acting Injectable Risperidone Make a Difference to the Real-Life Treatment of Schizophrenia? Results of the French Cohort for the General Study of Schizophrenia (CGS)
    Grimaldi-Bensouda, Lamiae
    Rouillon, Federic
    Astruc, Bernard
    Rossignol, Michel
    Benichou, Jacques
    Falissard, Bruno
    Limosin, Frederic
    Beaufils, Beatrice
    Vaiva, Guillaume
    Verdoux, Helene
    Moride, Yola
    Fabre, Alban
    Thibaut, Florence
    Abenhaim, Lucien
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 243 - 244
  • [9] Sexual dysfunction during treatment of schizophrenia: A largely underestimated problem? Baseline results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Dossenbach, M
    Brunner, E
    Levitt, L
    Becker, S
    Sammut, K
    Madrigal, L
    Roque, A
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S317 - S318
  • [10] Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
    Alonso, Jordi
    Croudace, Tim
    Brown, Jacqueline
    Gasquet, Isabelle
    Knapp, Martin R. J.
    Suarez, David
    Novick, Diego
    [J]. VALUE IN HEALTH, 2009, 12 (04) : 536 - 543
12345